Quick Answer
ENANTA PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $32.30 million for the year ending 2025.
- ENANTA PHARMACEUTICALS INC showed a decrease of -13.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ENANTA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on November 19, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $3.96 million | Q4 2012: $20.74 million | Q1 2013: $74.46 million | Q2 2013: $18.88 million | Q4 2013: $4.43 million | Q1 2014: $18.10 million | Q2 2014: $26.37 million | Q4 2014: $34.13 million | Q1 2015: $25.75 million | Q2 2015: $19.84 million | Q4 2015: $46.23 million | Q1 2016: $56.36 million | Q2 2016: $24.79 million | Q4 2016: $20.62 million | Q1 2017: $19.21 million | Q2 2017: $22.26 million | Q4 2017: $68.05 million | Q1 2018: $66.93 million | Q2 2018: $42.48 million | Q4 2018: $74.37 million | Q1 2019: $106.03 million | Q2 2019: $94.21 million | Q4 2019: $27.56 million | Q1 2020: $74.34 million | Q2 2020: $99.86 million | Q4 2020: $55.10 million | Q1 2021: $77.13 million | Q2 2021: $4.60 million | Q4 2021: $99.07 million | Q1 2022: $40.99 million | Q2 2022: $28.37 million | Q4 2022: $42.22 million | Q1 2023: $73.18 million | Q2 2023: $95.18 million | Q4 2023: $39.93 million | Q1 2024: $63.54 million | Q2 2024: $35.78 million | Q4 2024: $84.35 million | Q1 2025: $60.21 million | Q2 2025: $44.81 million | Q3 2025: $32.30 million | Q4 2025: $37.44 million.
- Over the full 16 years of available data (2010 to 2025), ENANTA PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 6,830.9%.
- Historical annual values: Fiscal year 2025: $32.30 million | Fiscal year 2024: $37.23 million | Fiscal year 2023: $85.39 million | Fiscal year 2022: $43.99 million | Fiscal year 2021: $57.21 million | Fiscal year 2020: $87.13 million | Fiscal year 2019: $51.23 million | Fiscal year 2018: $63.90 million | Fiscal year 2017: $65.68 million | Fiscal year 2016: $16.58 million | Fiscal year 2015: $21.73 million | Fiscal year 2014: $30.70 million | Fiscal year 2013: $8.86 million | Fiscal year 2012: $10.51 million | Fiscal year 2011: $6.84 million | Fiscal year 2010: $466.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: